Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Element Nutritional Sciences to Present at Canaccord Health & Wellness Conference
-
Biodesix to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
KnowBe4, Inc (KNBE) Prices Upsized 9M Share Follow-on Offering by Selling Stockholders at $25.75/sh
-
KnowBe4 Announces the Upsize and Pricing of Follow-On Offering by Selling Stockholders
-
KnowBe4 Announces the Upsize and Pricing of Follow-On Offering by Selling Stockholders
-
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December
-
Tactile Medical to Participate in Upcoming Investor Conferences in November and December
-
Youth INC raises a record $3 million at its Celebration Gala
-
UserTesting (USER) IPO: 9 Things to Know About the Upcoming $2.4 Billion UserTesting IPO
-
Scipher Medicine® to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
Toast Inc. (TOST) PT Raised to $66 at Canaccord Genuity After Its First Public Report
-
VerticalScope Announces Three Additional Acquisitions
-
SailPoint Technologies Holdings (SAIL) PT Raised to $75 at Canaccord Genuity
-
Benson Hill Management will Speak at the Roth Capital Conference and Canaccord Genuity Forum
-
QuoteMedia Announces 22% Revenue Growth for Q3 2021
-
Coinbase Global Inc. (COIN) PT Raised to $342 as Canaccord Genuity Looks Through Results to October Metrics
-
CloudMD to Present at Upcoming North American Investor Conferences
-
Castle Biosciences to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
Axogen, Inc. to Participate at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
Axogen, Inc. to Participate at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
7 Things to Know About the Upcoming $1.5 Billion IPO for Bitcoin Miner Iris Energy Limited (IREN)
-
Arizona Sonoran Announces Pricing of Initial Public Offering and Filing of Final Prospectus
-
CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum
-
7 Things to Know About the Upcoming $5+ Billion Braze (BRZE) IPO
-
WELL Health to Participate in Upcoming Investor Conferences
-
C3 Metals Announces Closing of Bought Deal Private Placement
-
Virgin Galactic (SPCE) PT Lowered to $44 but Customer Reservation Data Looks Impressive - Canaccord Genuity
-
Wellteq Digital Health Inc. Upcoming Investor Events
-
Quanta to Participate in Upcoming Virtual Investor Conferences
-
KORU Medical Systems to Participate in Two Upcoming Conferences
-
Flow Beverage to Present at Upcoming Investor Conferences
-
Taiga Announces Appointment of Eric Bussières to the Role of Chief Financial Officer
-
Canaccord Genuity Group Inc. Reports Second Quarter Fiscal 2022 Results
-
Aardvark and 2766604 Ontario Ltd. Announce Drill Results from FAD Property of 36.6m of 5.1 g/t Gold, 185.5 g/t Silver, 4.5% Lead and 6.0% Zinc (36.6m of 13.0 g/t Gold Equivalent) and Proposed $12 Mill
-
KnowBe4, Inc (KNBE) Announces Launch of Proposed 7M Share Follow-On Offering by Selling Stockholders
-
KnowBe4 Announces Launch of Proposed Follow-On Offering by Selling Stockholders
-
KnowBe4 Announces Launch of Proposed Follow-On Offering by Selling Stockholders
-
Corcept Therapeutics (CORT) Commences Tender Offer to Purchase up to 10 Million Shares of its Common Stock
-
Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 10 Million Shares of its Common Stock
-
TELA Bio to Participate in Three Upcoming Conferences
-
Curaleaf Expands its Presence in Three Key Growth Markets with Acquisition of Tryke Companies
-
TELA Bio to Participate in Three Upcoming Conferences
-
UserTesting (USER) Launches 14.17M Share IPO at $15-$17/sh
-
UserTesting Announces Launch of Initial Public Offering
-
EMX Completes First C$ 20.9 Million Tranche of C$ 21.45 Million Unit Private Placement
-
Curaleaf Holdings, Inc. (CURLF) Expands its Presence in Three Key Growth Markets with Acquisition of Tryke Companies
-
Motion Acquisition Corp. (MOTN) and DocGo Announce Closing of Business Combination, will Begin Trading on Nasdaq Under the Symbol "DCGO"
-
Motion Acquisition Corp. and DocGo Announce Closing of Business Combination, will Begin Trading on Nasdaq Under the Symbol "DCGO"
-
NervGen Pharma Announces Increase to Bought Deal Financing to $8.0 Million
-
Cardiol Therapeutics Announces Closing of US$50 Million Public Offering

